ArticleAnnals of hematology2026
Trends and projections of high body mass index-associated non-hodgkin lymphoma burden (1990-2040): A global burden of disease 2021 analysis.
Article in Annals of hematology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Elevated body mass index (BMI) has been established as an independent risk factor for non-Hodgkin lymphoma (NHL), yet the global distribution and geographic heterogeneity of the attributable disease burden remain inadequately characterized. Drawing on data from the Global Burden of Disease study, this research examined temporal changes in disability-adjusted life years (DALYs) and deaths due to high-BMI-associated NHL from 1990 to 2021, quantified cross-national inequalities using the slope index of inequality (SII) and the concentration index (CI), and projected the burden through 2040 with an autoregressive integrated moving average model (ARIMA). The global age-standardized DALY rate (ASDR) increased from 3.45 per 100,000 in 1990 to 4.00 in 2021 and is projected to reach 4.63 by 2040; the age-standardized mortality rate (ASMR) rose from 0.13 to 0.15 per 100,000 and is expected to climb to 0.17 by 2040. Absolute inequality widened substantially, with the SII rising from 0.35 to 1.44, while the CI changed from -0.39 to -0.21, indicating a modest reduction in relative inequality but a persistent concentration of the burden in regions with a lower socio-demographic index. Both ASDR and ASMR were positively correlated with the socio-demographic index (SDI) across regions and countries. These findings demonstrate a continuously escalating global health burden of high-BMI-associated NHL with marked regional disparities, highlighting the urgent need for region-specific obesity prevention strategies and improved clinical management of NHL.Clinical Trial: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.